Octostim (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Octostim, is a synthetic analogue of the natural hormone vasopressin presented as a tablet for oral use. It is employed to manage conditions related to water balance and certain bleeding disorders in both adults and children.

GNH USA supplies Octostim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin Acetate acts on the vasopressin pathway to control water reabsorption and coagulation factors. - Central diabetes insipidus: helps normalize urine output and plasma sodium levels. - Nocturnal enuresis: reduces nighttime bladder episodes in children. - Mild hemophilia A and von Willebrand disease type 1: raises plasma factor VIII and von Willebrand factor levels to improve clotting.

Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nasal congestion or dryness (if administered intranasally). - Nausea or abdominal discomfort. - Hyponatraemia: mild reduction in serum sodium. - Flushing or feeling of warmth.

Serious or Rare Side Effects: - Severe hyponatraemia leading to seizures or coma. - Thromboembolic events such as deep‑vein thrombosis. - Allergic reactions including rash, itching or anaphylaxis. - Cardiac arrhythmias associated with electrolyte shifts. - Acute pulmonary oedema in patients with fluid overload.

Desmopressin requires careful monitoring in several clinical situations. - Fluid restriction: limit intake to 1‑1.5 L/24 h when therapy is initiated. - Hyponatraemia risk: check serum sodium before and during treatment. - Cardiovascular disease: use cautiously in patients with heart failure or coronary artery disease. - Pregnancy and lactation: evaluate benefit‑risk before use. - Concomitant anticoagulants: monitor clotting parameters closely. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Desmopressin can interact with several medicines that affect water balance or coagulation.

Major Interactions (Avoid): - NSAIDs (e.g., ibuprofen, naproxen): increase risk of hyponatraemia. - Carbamazepine and other enzyme inducers: reduce desmopressin plasma levels. - Anticoagulants (warfarin, DOACs): may potentiate bleeding risk when used for haemostatic indications.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): amplify water‑retention effects. - Selective serotonin reuptake inhibitors (SSRIs): modestly raise hyponatraemia risk. - Hormonal contraceptives: may alter fluid balance, requiring sodium monitoring.